| Literature DB >> 28948633 |
Zhiwei Zhang1, Ruizhe Chen2, Guoxing Soon3, Hui Zhang4.
Abstract
Adaptive enrichment designs (AEDs) of clinical trials allow investigators to restrict enrollment to a promising subgroup based on an interim analysis. Most of the existing AEDs deal with a small number of predefined subgroups, which are often unknown at the design stage. The newly developed Simon design offers a great deal of flexibility in subgroup selection (without requiring pre-defined subgroups) but does not provide a procedure for estimating and testing treatment efficacy for the selected subgroup. This article proposes a 2-stage AED which does not require predefined subgroups but requires a prespecified algorithm for choosing a subgroup on the basis of baseline covariate information. Having a prespecified algorithm for subgroup selection makes it possible to use cross-validation and bootstrap methods to correct for the resubstitution bias in estimating treatment efficacy for the selected subgroup. The methods are evaluated and compared in a simulation study mimicking actual clinical trials of human immunodeficiency virus infection.Entities:
Keywords: bootstrap; cross-validation; precision medicine; predictive biomarker; subgroup analysis; treatment effect heterogeneity
Mesh:
Year: 2017 PMID: 28948633 DOI: 10.1002/sim.7497
Source DB: PubMed Journal: Stat Med ISSN: 0277-6715 Impact factor: 2.373